Description
A CB2 receptor inverse agonist (Ki = 435 nM for recombinant human CB2); selective for CB2 over CB1 receptors (Ki = >20 µM); reduces basal production of inositol phosphate and increases forskolin-induced accumulation of cAMP in HEK293 cells expressing human CB2 receptors from 0.001-1 µM; inhibits LPS-induced NO and PGE2 production in J774 macrophages
Formal name: 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl)-ethanone
Synonyms: BML-190|Indomethacin Morpholinylamide|LM-4131
Molecular weight: 426.9
CAS: 2854-32-2
Purity: ≥98%
Formulation: A crystalline solid